Quantbot Technologies LP Cue Biopharma, Inc. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.41 - $12.28 $13,362 - $37,208	-3,030 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$10.86 - $17.85 $32,905 - $54,085	3,030 New	3,030 $34,000
Q2 2021 Aug 12, 2021	SELL	$10.9 - $14.53 $6,540 - $8,718	-600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$15.05 - $23.54 $9,030 - $14,124	600 New	600 $9,000

11.9M

22K

1.2K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $47.4M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.